Home > Neurology > Lyme neuroborreliosis does not seem to boost psychiatric risk

Lyme neuroborreliosis does not seem to boost psychiatric risk


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Psychiatry
Reuters Health - 13/10/2020 - Lyme neuroborreliosis was not associated with a higher risk of developing psychiatric disease requiring hospitalization or prescription medication in a matched cohort study in Denmark. "The increased use of anxiolytics, hypnotics, sedatives and antidepressants was somewhat surprising," Malte Tetens of Copenhagen University Hospital told Reuters Health by email. "However, as we analyzed the data, it became clear that part of this increased medication might be explained by management of neuropathic pain following diagnosis." As reported in JAMA Psychiatry, the study included 2,897 patients (56.8% men) with Lyme neuroborreliosis diagnosed from 1995-2015 and 28, 970 matched controls. The median age was 45.7 years. Compared with controls, Lyme disease neuroborreliosis patients had no higher risk for developing psychiatric diseases overall (HR, 1.1) or any subcategory of psychiatric disease - i.e., mental and behavioral disorders owing...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on